ArticleCurrent protocols in stem cell biology2018

CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.

Navin Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.